Scienture Holdings Revenue

Scienture Holdings had revenue of $128.20K in the twelve months ending June 30, 2025, down -76.24% year-over-year. In the year 2024, Scienture Holdings had annual revenue of $136.64K, down -89.98%.

Revenue (ttm)

$128.20K

Revenue Growth

-76.24%

P/S Ratio

50.67

Revenue / Employee

$6,747

Employees

Market Cap

25.78M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	136.64K	-1.23M	-89.98%
Dec 31, 2023	1.36M	1.06M	354.61%
Dec 31, 2022	300.00K	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

SCNX News

3 days ago - SCIENTURE Announces Addition of Arbli™ (Losartan Potassium) to Formularies of Major National Health Plans - GlobeNewsWire
15 days ago - SCIENTURE Announces Start of Commercial Sales and Fulfillment of First Orders for Arbli™ (Losartan Potassium) - GlobeNewsWire
22 days ago - SCIENTURE'S Arbli™ Becomes First FDA-Approved Ready-to-Use Liquid Losartan Available Through Major U.S. Wholesalers - GlobeNewsWire
25 days ago - Wellgistics Health Announces Executive Management and Board Changes - Accesswire
7 weeks ago - SCIENTURE Secures PBM-Led GPO Rebate Agreement to Drive Expanded Commercial Coverage and Formulary Access for Arbli™(losartan potassium) in the $256M U.S. Losartan Market - GlobeNewsWire
3 months ago - Scienture Holdings, Inc. Announces Pricing of $3.9 Million Registered Direct Offering of Common Stock - GlobeNewsWire
3 months ago - SCIENTURE announces the shipment of launch quantities of Arbli™ (losartan potassium Oral Suspension) to its 3PL/Distribution Center and receipt of first wholesaler order, marking major commercialization milestones. - GlobeNewsWire
3 months ago - Scienture Holdings, Inc. Obtains $1.2 Million in Bridge Funding - GlobeNewsWire

More News